Market Overview

12 Biggest Mid-Day Losers For Friday

Share:
  • TOP SHIPS Inc (NASDAQ: TOPS) shares dipped 57.6 percent to $1.02. TOP SHIPS enacted a 1:15 reverse stock split today.
  • ParkerVision, Inc. (NASDAQ: PRKR) shares dropped 13.9 percent to $2.10. ParkerVision disclosed that the German Court decision in infringement case against Apple awaits validity ruling.
  • Invivo Therapeutics Holdings Corp (NASDAQ: NVIV) shares dropped 13 percent to $3.17.
  • BlackBerry Ltd (NASDAQ: BBRY) shares declined 12.4 percent to $9.69. BlackBerry reported better-than-expected earnings for its third quarter, while revenue missed expectations.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares tumbled 12 percent to $29.69 after the company reported weaker-than-expected results for its first quarter. Deutsche Bank lowered the price target for Bed Bath & Beyond from $36 to $31.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) dipped 11.8 percent to $10.18. Ocular Therapeutix disclosed that Antony Mattessich will succeed Dr. Amar Sawhney as CEO of the company. Morgan Stanley downgraded Ocular Therapeutix from Overweight to Equal-Weight.
  • Meridian Waste Solutions Inc (NASDAQ: MRDN) shares dropped 11.4 percent to $2.48.
  • American Software, Inc. (NASDAQ: AMSWA) fell 7 percent to $11.13. American Software reported preliminary Q4 adjusted earnings of $0.09 per share on revenue of $26.3 million.
  • Celsion Corporation (NASDAQ: CLSN) declined 6.8 percent to $2.45. Celsion reported cancellation of registered direct offering on Thursday.
  • bluebird bio Inc (NASDAQ: BLUE) shares slipped 6.6 percent to $110.65 after the company issued new data from HGB-205 study of LentiGlobin drug product.
  • Leju Holdings Ltd (ADR) (NYSE: LEJU) dropped 3.3 percent to $2.38. JP Morgan downgraded Leju Holdings from Neutral to Underweight.
  • Clovis Oncology Inc (NASDAQ: CLVS) fell 3.2 percent to $93.71. Oppenheimer initiated coverage on Clovis Oncology with a Perform rating.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

 

Related Articles (AMSWA + BB)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

What To Expect From Clovis Oncology Following Rubraca Approval

BuildFax Gives Insurance Companies A Data-Driven Edge On Risk Assessment